Tech Company Financing Transactions
Axcella Health Funding Round
Axcella Health closed a $11 million financing round on 9/16/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/16/2015
Transaction Type
Venture Equity
Amount
$11,017,967
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Publicly-held
Industry
Consumer
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Axcella Health (Nasdaq: AXLA) is a pioneer in developing transformative medicines for patients with diseases in which disrupted amino acid biology plays a central role.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Connelly
Chief Financial Officer
Thomas Leggett
Chief Information Officer
David Berry
Chief Medical Officer
Manu Chakravarthy
VP - Bus. Development
Ivana Magovcevic-Liebisch
VP - R & D
Michael Hamill
VP - R & D
Tony Tramontin
Browse more venture capital transactions:
Prev: 9/16/2015: Comfy venture capital transaction
Next: 9/16/2015: Proteostasis Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs